Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Bajaj Healthcare
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 154 | 130 | 101 | 109 | 134 | 132 | 133 | 123 | 154 | 149 | 148 | 161 | 153 |
| Expenses + | 132 | 108 | 82 | 89 | 118 | 108 | 109 | 101 | 143 | 124 | 121 | 131 | 130 |
| Operating Profit | 22 | 22 | 19 | 20 | 16 | 24 | 25 | 22 | 12 | 25 | 27 | 31 | 23 |
| OPM % | 14% | 17% | 19% | 18% | 12% | 19% | 18% | 18% | 8% | 16% | 18% | 19% | 15% |
| Other Income + | -7 | -55 | -7 | -7 | -36 | -0 | 4 | -1 | 13 | 1 | 0 | 1 | -34 |
| Interest | 6 | 9 | 8 | 7 | 6 | 8 | 8 | 6 | 6 | 5 | 6 | 6 | 6 |
| Depreciation | 5 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 6 | 7 | 7 | 8 |
| Profit before tax | 5 | -48 | -3 | -1 | -33 | 9 | 14 | 8 | 11 | 14 | 15 | 19 | -24 |
| Tax % | 21% | -0% | 4% | 58% | -10% | 23% | 30% | -39% | 1% | 17% | 24% | 17% | -6% |
| Net Profit + | 4 | -48 | -3 | -2 | -30 | 7 | 9 | 12 | 11 | 12 | 11 | 16 | -23 |
| EPS in Rs | 1.30 | -17.47 | -1.25 | -0.80 | -10.84 | 2.58 | 3.00 | 3.71 | 3.54 | 3.75 | 3.52 | 4.96 | -6.79 |
Financials of Bajaj Healthcare
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 218 | 223 | 231 | 327 | 370 | 410 | 657 | 680 | 646 | 473 | 543 | 611 |
| Expenses + | 189 | 193 | 200 | 288 | 327 | 362 | 521 | 561 | 534 | 397 | 460 | 506 |
| Operating Profit | 29 | 30 | 31 | 39 | 43 | 48 | 136 | 119 | 112 | 76 | 83 | 105 |
| OPM % | 13% | 14% | 13% | 12% | 12% | 12% | 21% | 17% | 17% | 16% | 15% | 17% |
| Other Income + | 0 | 0 | 2 | 2 | 1 | 7 | 7 | 1 | -19 | -105 | 16 | -32 |
| Interest | 8 | 8 | 8 | 8 | 8 | 7 | 8 | 13 | 18 | 30 | 28 | 22 |
| Depreciation | 9 | 9 | 11 | 11 | 11 | 12 | 16 | 18 | 17 | 28 | 28 | 28 |
| Profit before tax | 12 | 14 | 14 | 23 | 24 | 36 | 119 | 90 | 58 | -86 | 43 | 23 |
| Tax % | 37% | 39% | 43% | 33% | 33% | 30% | 30% | 20% | 25% | -3% | 7% | 33% |
| Net Profit + | 8 | 8 | 8 | 15 | 16 | 25 | 83 | 71 | 43 | -84 | 40 | 16 |
| EPS in Rs | 8.34 | 3.04 | 2.83 | 5.50 | 5.91 | 9.14 | 30.11 | 25.87 | 15.59 | -30.36 | 12.51 | 4.68 |
| Dividend Payout % | 0% | 0% | 0% | 5% | 0% | 0% | 5% | 6% | 6% | -3% | 8% | 0% |
Financials of Bajaj Healthcare
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 7 | 7 | 7 | 7 | 14 | 14 | 14 | 14 | 14 | 16 | 17 |
| Reserves | 78 | 82 | 92 | 107 | 122 | 164 | 245 | 315 | 354 | 265 | 450 | 516 |
| Borrowings + | 70 | 81 | 75 | 87 | 81 | 91 | 181 | 257 | 415 | 333 | 223 | 249 |
| Other Liabilities + | 38 | 39 | 45 | 68 | 57 | 74 | 86 | 136 | 115 | 154 | 144 | 141 |
| Total Liabilities | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 898 | 765 | 833 | 923 |
| Fixed Assets + | 108 | 130 | 128 | 127 | 128 | 162 | 208 | 270 | 366 | 253 | 238 | 248 |
| CWIP | 1 | 1 | 0 | 2 | 1 | 5 | 57 | 52 | 22 | 7 | 3 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 79 | 78 | 91 | 140 | 137 | 170 | 260 | 399 | 510 | 506 | 591 | 667 |
| Total Assets | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 898 | 765 | 833 | 923 |
Financials of Bajaj Healthcare
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 28 | 25 | 22 | 17 | 25 | 21 | 44 | 1 | -22 | 92 | 22 | 58 |
| Cash from Investing Activity + | -17 | -31 | -8 | -12 | -13 | -28 | -109 | -75 | -93 | -11 | -15 | -48 |
| Cash from Financing Activity + | -11 | 5 | -13 | 2 | -13 | 3 | 75 | 62 | 131 | -97 | -6 | 24 |
| Net Cash Flow | -0 | -0 | 0 | 7 | -0 | -4 | 10 | -12 | 16 | -16 | 0 | 35 |
| Free Cash Flow | 11 | -6 | 14 | 5 | 11 | -2 | -70 | -74 | -115 | 73 | 10 | 18 |
| CFO/OP | 99% | 100% | 88% | 57% | 89% | 62% | 58% | 9% | -10% | 138% | 32% | 53% |
Financials of Bajaj Healthcare
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 70 | 83 | 90 | 77 | 88 | 55 | 99 | 110 | 139 | 169 | 140 |
| Inventory Days | 50 | 56 | 45 | 57 | 45 | 54 | 94 | 143 | 199 | 206 | 206 | 249 |
| Days Payable | 63 | 46 | 51 | 74 | 45 | 80 | 67 | 94 | 81 | 128 | 122 | 133 |
| Cash Conversion Cycle | 73 | 80 | 78 | 73 | 77 | 62 | 82 | 148 | 228 | 217 | 254 | 256 |
| Working Capital Days | -11 | -17 | -4 | 0 | 12 | 24 | 34 | 40 | 27 | -0 | 140 | 119 |
| ROCE % | 16% | 13% | 13% | 16% | 16% | 18% | 36% | 20% | 14% | 8% | 11% | 11% |
Focused growth in six core therapy areas: cardiology, pain management, women's health, CNS, transplant, and ophthalmology, which contribute 40-50% of…
Expansion plans supported by capex of INR 200-250 crores annually, with 60% towards expansion/new products and 40% towards efficiency improvements. Key concall…
The company is confident of achieving 20%+ volume growth backed by steady ramp-up in Jammu and existing facilities. Key concall takeaways from Innova Captab…
Chronic respiratory segment in India showing over 25% growth; oncology and cardiovascular segments also strong. Key concall takeaways from Glenmark…